We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.
FDA continues to focus on the safe use of benzodiazepines. One critical element of increasing our understanding of their benefits and risks is through collaborations and stakeholder outreach.